z-logo
Premium
Naloxone‐induced reversal of clonidine, but not hydralazine, hypotension
Author(s) -
Bennett Debra A.,
DeFeo John J.,
Elko Edward E.,
Lal Harbans
Publication year - 1982
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.430020207
Subject(s) - clonidine , hydralazine , (+) naloxone , medicine , blood pressure , anesthesia , antagonist , opiate , receptor
Normotensive rats of the Sprague‐Dawley strain were administered either the centrally acting hypotensive drug clonidine (0.16 mg/kg IP) or the peripherally acting hypotensive drug hydralazine (1.25 mg/kg IP) to induce reliable hypotension (blood pressure reductions of 60–90 mm Hg), as measured by a tail cuff procedure. The opiate antagonist, naloxone (10–20 mg/kg IP), reversed clonidine but not hydralazine hypotension. Naloxone also failed to reverse hydralazine's hypotensive action in rats made hypertensive by renal ligation. Naloxone's reversal of clonidine (0.01 mg/kg IV) hypotension was confirmed in experiments in which blood pressure was measured through direct cannulation of the carotid artery. It is suggested that naloxone's antagonism of clonidine hypotension is located at a central nervous system site, and that clonidine hypotension may be mediated through an interaction with the brain opiate systems.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here